Summary
The aim of the present study was to investigate the influence of cyclosporin A on the course of multiple low dose streptozotocin induced diabetes in mice, an animal model for human type I diabetes mellitus. C57BL/Ks mice were treated on five consecutive days with intraperitoneal injections of steptozotocin or citiric acid buffer. Thirty min before the injections the animals were given cyclosporin A (10 or 50 mg/kg body weight) or saline. Cyclosporin A did not protect against the hypoglycaemia and at the higher dose it potentiated the diabetogenic effect. Furthermore, cyclosporin A did not affect the development of insulitis when the pancreatic glands were examined by light microscopy. Using a technique for monitoring vascular permeability in vivo with the aid of the pigment Monastral Blue B, it was found that the development of diabetes was accompanied by an increased vascular leakage. Control animals treated with cyclosporin A also showed an increased islet staining with Monastral Blue B. The data indicate that cyclosporin A potentiates diabetes induced by low doses of streptozotocin. This can be attributed to a direct toxic effect of cyclosporin A on the pancretic B-cells and may also be due to an increased vascular leakage induced by cyclosporin A. The latter would allow an increased migration of inflammatory cells into the islets and the consequent release of B-cytotoxic substances.
Similar content being viewed by others
References
Andersson A, Borg H, Hallberg A, Sandier S, Schnell A, Hellerström C (1984) Long-term effects of cyclosporin A on cultured mouse pancreatic islets. Diabetologia 27:66–69
Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M (1986) Cytotoxicity of human pI 7 interleukin 1 for pancreatic islets of Langerhans. Science 232:1545–1547
Beppu H, Maruta K, Kürner T, Kolb H (1987) Diabetogenic action of streptozotocin: essential role of membrane permeability. Acta Endocrinologica 114:90–95
Bonnevie-Nielsen V, Steffes MW, Lernmark Å (1981) A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes 30:424–429
Calne RY, White DJG, Evans DB, Thiru S, Henderson RG, Hamilton DV, Rolles K, McMaster P, Dully TJ, MacDougall GRD, Williams R (1981) Cyclosporin A in cadaveric organ transplantation. Br Med J 282:934–936
Feutren G, Assan R, Karsenty G, Du Rostu H, Sirmai J, Papol L, Vialettes B, Vexiau P, Rodier M, Lallemand A, Bach J-F (1986) Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Lancet i:119–124
Hahn HJ, Laube F, Lucke S, Klöting I, Kohnert KD, Warzock R (1986) Toxic effects of cyclosporin A on the endocrine pancreas of Wistar rats. Transplantation 41:44–47
Helmchen U, Schmidt WE, Siegel EG, Creutzfeldt W (1984) Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats. Diabetologia 27:416–418
Jansson L, Hellerström C (1981) A rapid method of visualizing the pancreatic islets for studies of islet capillary blood flow using non-radioactive microspheres. Acta Physiol Scand 113:371–374
Jansson L, Sandler S (1986) Alloxan-induced diabetes in the mouse: time course of pancreatic B-cell destruction as reflected in an increased islet vascular permeability. Virchows Arch A (Pathol Anat) 410:17–21
Kojima Y, Sandler S, Andersson A (1986) Cyclosporine inhibits mouse islet cell replication. Transplant Proc 18:37–39
Kolb H, Oschilewski M, Schwab E, Oschilewski U, Kiesel U (1985) Effect of cyclosporin A on low-dose streptozotocin diabetes in mice. Diabetes Res 2:191–193
Laupacis A, Gardell C, Dupre J, Stiller CR, Keown P, Wallace AC, Thibert P (1983) Cyclosporin prevents diabetes in BB Wistar rats. Lancet i:10–11
Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415–417
Mandrup-Poulsen T, Bendtzen K, Nielsen JH, Bendixen G, Nerup J (1985) Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 40:424–429
Mandrup-Poulsen T, Bendtzen K, Nerup J, Egeberg J, Nielsen JH (1986) Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy 41:250–259
Merion RM, White DJG, Thiru S, Evans DB, Calne RY (1984) Cyclosporine: five years experience in cadaveric renal transplantation. N Engl J Med 310:148–154
Nerup J, Lernmark Å (1981) Autoimmunity in insulin-dependent diabetes. Am J Med 70:135–141
Nussenblatt RB, Rodrigues MM, Levario SS, Salinas-Carmona MC (1981) Cyclosporin A: inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest 67:1228–1231
Sandler S (1984) Protection by dimethyl urea against hyperglycaemia, but not insulitis, in low-dose streptozotocin induced diabetes in the mouse. Diabetologia 26:386–388
Sandler S, Andersson A (1985) Modulation of streptozotocin-induced hyperglycemia in the mouse. Acta Pathol Microbiol Immunol Scand (Sect A) 93:93–98
Sandler S, Jansson L (1985) Vascular permeability of pancreatic islets after administration of streptozotocin. Virchows Arch A (Pathol Anat) 407:359–367
Schwab E, Burkart V, Freytag G, Kiesel U, Kolb H (1986) Inhibition of immune-mediated low-dose streptozotocin diabetes by agents which reduce vascular permeability. Immunopharmacology 12:17–21
Sestier C, Odent-Pogu S, Bonneville M, Maurel C, Lang F, Sai P (1985) Cyclosporin enhances diabetes induced by low-dose streptozotocin treatment in mice. Immunol Lett 10:57–60
Stiller CR, Laupacis A, Dupre J, Jenner MR, Known PA, Rodger RA, Wolff BMJ (1983) Cyclosporine for treatment of early type I diabetes: preliminary results. N Engl J Med 308:1226–1227
Vladutio AO (1983) Effect of cyclosporine on experimental autoimmune thyroiditis in mice. Transplantation 35:518–520
Author information
Authors and Affiliations
Additional information
This work was supported by grants from the Swedish Diabetes Association, the Swedish Medical Research Council (12X-109, 12X-8273; 12P-7680), the Clas Groschinsky Memorial Foundation, the Nordic Insulin Fund, the Ernfors Family Fund, the Swedish Society of Medicine and the Hoechst Diabetes Foundation
Rights and permissions
About this article
Cite this article
Jansson, L., Sandler, S. The influence of cyclosporin A on the vascular permeability of the pancreatic islets and on diabetes induced by multiple low doses of streptozotocin in the mouse. Vichows Archiv A Pathol Anat 412, 225–230 (1988). https://doi.org/10.1007/BF00737146
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00737146